News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

As The Pursuit For Allergan Inc. (AGN) Continues, Valeant Pharmaceuticals International (VRX) Hunts For More Deals—Including Contact Lenses


8/1/2014 6:06:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Valeant Pharmaceuticals International Inc (VRX.TO) on Thursday said it remains on the hunt for other companies, including makers of innovative contact lenses, as it presses on with efforts to take over Botox-maker Allergan Inc (AGN.N).

On a conference call with investors, Valeant Chief Executive Officer Michael Pearson said the company will not be content to remain the No. 4 global player in the contact lens industry.

Valeant officials said Allergan shareholders would profit more through a merger with Toronto-based Valeant than remaining a standalone company.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES